tradingkey.logo

908 Devices Inc.

MASS
6.550USD
+0.350+5.65%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
236.58MMarktkapitalisierung
VerlustKGV TTM

908 Devices Inc.

6.550
+0.350+5.65%

mehr Informationen über 908 Devices Inc. Unternehmen

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.

908 Devices Inc. Informationen

BörsenkürzelMASS
Name des Unternehmens908 Devices Inc
IPO-datumDec 18, 2020
CEOKnopp (Kevin J)
Anzahl der mitarbeiter246
WertpapierartOrdinary Share
GeschäftsjahresendeDec 18
Addresse44 Third Avenue
StadtBURLINGTON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl01803
Telefon19787294478
Websitehttps://908devices.com/
BörsenkürzelMASS
IPO-datumDec 18, 2020
CEOKnopp (Kevin J)

Führungskräfte von 908 Devices Inc.

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.26M
+30000.00%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
962.12K
--
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
74.33K
+11364.00%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
+11364.00%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
+11364.00%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
+6485.00%
Mr. John Kenneweg
Mr. John Kenneweg
Vice President - Government
Vice President - Government
--
--
Mr. Joseph H. (Joe) Griffith, IV
Mr. Joseph H. (Joe) Griffith, IV
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. Michael Scott Turner, J.D.
Mr. Michael Scott Turner, J.D.
Chief Legal and Administrative Officer, Company Secretary
Chief Legal and Administrative Officer, Company Secretary
--
--
Mr. E. Kevin Hrusovsky
Mr. E. Kevin Hrusovsky
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.26M
+30000.00%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
962.12K
--
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
74.33K
+11364.00%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
+11364.00%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
+11364.00%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
+6485.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Device sales revenue
9.11M
65.08%
Recurring revenue
4.84M
34.54%
Contract revenue
54.00K
0.39%
Nach RegionUSD
Name
Umsatz
Anteil
United States
11.23M
80.19%
Europe,Middle East & Africa
1.54M
10.98%
Asia Pacific
793.00K
5.66%
Americas other
443.00K
3.16%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Device sales revenue
9.11M
65.08%
Recurring revenue
4.84M
34.54%
Contract revenue
54.00K
0.39%

Aktionärsstatistik

Aktualisiert: Sat, Feb 7
Aktualisiert: Sat, Feb 7
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
ARCH Venture Partners
15.82%
AWM Investment Company, Inc.
14.37%
First Light Asset Management, LLC
12.93%
State Street Investment Management (US)
6.35%
ARK Investment Management LLC
5.40%
Andere
45.13%
Aktionäre
Aktionäre
Anteil
ARCH Venture Partners
15.82%
AWM Investment Company, Inc.
14.37%
First Light Asset Management, LLC
12.93%
State Street Investment Management (US)
6.35%
ARK Investment Management LLC
5.40%
Andere
45.13%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
48.29%
Investment Advisor
22.47%
Venture Capital
15.95%
Individual Investor
8.73%
Hedge Fund
3.08%
Research Firm
1.78%
Pension Fund
0.65%
Bank and Trust
0.08%
Insurance Company
0.03%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
229
32.89M
90.87%
-5.27M
2025Q3
224
29.28M
81.15%
-3.78M
2025Q2
226
29.86M
82.76%
-3.27M
2025Q1
235
29.47M
83.22%
+34.34K
2024Q4
242
25.43M
73.04%
-4.66M
2024Q3
246
27.53M
79.50%
-3.86M
2024Q2
248
28.48M
83.77%
-4.52M
2024Q1
241
29.63M
90.49%
-5.18M
2023Q4
255
31.02M
95.84%
-3.81M
2023Q3
261
30.10M
93.52%
-5.15M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
ARCH Venture Partners
5.73M
15.82%
--
--
Apr 17, 2025
AWM Investment Company, Inc.
5.20M
14.37%
--
--
Sep 30, 2025
First Light Asset Management, LLC
4.68M
12.93%
+2.17M
+86.45%
Nov 30, 2025
State Street Investment Management (US)
2.30M
6.35%
+11.51K
+0.50%
Sep 30, 2025
ARK Investment Management LLC
1.95M
5.4%
-694.51K
-26.22%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.60M
4.41%
-20.56K
-1.27%
Sep 30, 2025
The Vanguard Group, Inc.
1.42M
3.93%
-9.38K
-0.66%
Sep 30, 2025
Knopp (Kevin J)
1.26M
3.49%
+30.00K
+2.43%
May 15, 2025
Brown (Christopher D)
962.12K
2.66%
--
--
Apr 17, 2025
GM Advisory Group, LLC
678.09K
1.87%
-487.20K
-41.81%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
ARK Genomic Revolution ETF
1.43%
State Street SPDR S&P Kensho Future Security ETF
0.86%
State Street SPDR S&P Kensho New Econ Comp ETF
0.5%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Mehr Anzeigen
ARK Genomic Revolution ETF
Anteil1.43%
State Street SPDR S&P Kensho Future Security ETF
Anteil0.86%
State Street SPDR S&P Kensho New Econ Comp ETF
Anteil0.5%
iShares Micro-Cap ETF
Anteil0.04%
Avantis US Small Cap Equity ETF
Anteil0.02%
iShares Russell 2000 ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
Global X Russell 2000 ETF
Anteil0.01%
iShares Russell 2000 Growth ETF
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI